What is the duration of urea treatment for hyponatremia (low sodium levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Duration of Urea Treatment for Hyponatremia

The duration of urea treatment for hyponatremia varies depending on the study and patient response.

  • A study published in 2025 1 found that a median dose of 30 g/day of urea for 4 days (interquartile range 2-7 days) increased plasma sodium from 127 to 134 mmol/L and normalized hyponatremia in 47% of treatment episodes.
  • Another study from 2020 2 reported that urea was administered over a median of 5 days (range 2-10 days) to hospitalized patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
  • A 2022 study 3 collected serum sodium levels for 4 days or until urea was discontinued, whichever occurred first, and found that median serum sodium increased 2 mEq/L per day after urea administration at a median dose of 30 g/day.
  • A 2019 study 4 used urea to treat fluid restriction-refractory hyponatraemia and reported that 50 treatment episodes (64.1%) resulted in serum sodium ≥130 mmol/L at 72 hours.

Factors Associated with Treatment Duration

Several factors are associated with the duration of urea treatment for hyponatremia, including:

  • Older age 1
  • Lower baseline plasma sodium 1
  • Higher cumulative urea dose 1
  • Concurrent fluid restriction 1
  • Patient tolerance and side effects, such as distaste 2, 3, 4

Treatment Outcomes

The treatment outcomes for urea in hyponatremia are generally positive, with:

  • Increased plasma sodium levels 1, 2, 3, 4
  • Normalization of hyponatremia in a significant proportion of patients 1, 2, 4
  • Low rates of overcorrection and severe side effects 1, 2, 3, 4

References

Research

Clinical factors associated with hyponatremia correction during treatment with oral urea.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025

Research

Safety and Efficacy of Urea for Hyponatremia.

Hospital pharmacy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.